Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 24th:
Shenandoah Telecommunications Company (SHEN - Free Report) : This telecom services provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings jumping 34.2% over the last 60 days.
Shenandoah Telecommunications Co Price and Consensus
Shenandoah’s shares gained 17.1% over the last one month more than S&P 500’s gain of 0.4%. The company possesses a Momentum Score of B.
Shenandoah Telecommunications Co Price
Workiva Inc. (WK - Free Report) : This cloud solutions provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 26% over the last 60 days.
Workiva Inc. Price and Consensus
Workiva’s shares gained 20.9% over the last one month. The company possesses a Momentum Score of A.
Workiva Inc. Price
Everi Holdings Inc. (EVRI - Free Report) : This technology solutions provider for the casino gaming industry has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 75% over the last 60 days.
Everi Holdings Inc. Price and Consensus
Everi’s shares gained 12.4% over the last one month. The company possesses a Momentum Score of B.
Everi Holdings Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 24th:
Shenandoah Telecommunications Company (SHEN - Free Report) : This telecom services provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings jumping 34.2% over the last 60 days.
Shenandoah Telecommunications Co Price and Consensus
Shenandoah’s shares gained 17.1% over the last one month more than S&P 500’s gain of 0.4%. The company possesses a Momentum Score of B.
Shenandoah Telecommunications Co Price
Workiva Inc. (WK - Free Report) : This cloud solutions provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 26% over the last 60 days.
Workiva Inc. Price and Consensus
Workiva’s shares gained 20.9% over the last one month. The company possesses a Momentum Score of A.
Workiva Inc. Price
Everi Holdings Inc. (EVRI - Free Report) : This technology solutions provider for the casino gaming industry has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 75% over the last 60 days.
Everi Holdings Inc. Price and Consensus
Everi’s shares gained 12.4% over the last one month. The company possesses a Momentum Score of B.
Everi Holdings Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on SHEN - FREE
Get the latest research report on WK - FREE
Get the latest research report on EVRI - FREE